Latest News in the pharma Industry

All

Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio

Glenmark Pharmaceuticals licenses small molecule oncology compound from APC Therapeutics to expand IO portfolio

20 Jun 2017

The compound has the potential to be used as a monotherapy or in combination with approved therapies to address unmet needs in cancer treatment.

Read more 
Merck Ventures creates new immuno-oncology company iOnctura

Merck Ventures creates new immuno-oncology company iOnctura

20 Jun 2017

iOnctura is set up to develop a pipeline of assets targeting immunosuppression in the tumour microenvironment.

Read more 
FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

FDA accepts Amgen's sBLA to expand indication for Xgeva to include multiple myeloma patients

19 Jun 2017

Xgeva is indicated for the prevention of skeletal-related events in patients with bone metastases from solid tumours and is the number one prescribed agent by oncologists for this indication in the US.

Read more 
J&J completes acquisition of Actelion

J&J completes acquisition of Actelion

19 Jun 2017

Actelion will now become part of the Janssen Pharmaceutical Companies of J&J.

Read more 
Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

Sandoz receives approval in Europe for Rixathon to treat blood cancers and immunological diseases

19 Jun 2017

Sandoz now has four biosimilars approved in Europe - more than any other company.

Read more 
FDA updates on Pfizer drug shortages

FDA updates on Pfizer drug shortages

18 Jun 2017

Pfizer says shortages caused by manufacturing, distribution and third party delays.

Read more 
BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

BMS to sell manufacturing facility in Swords, Ireland to SK Biotek

16 Jun 2017

Company shifts manufacturing focus in Ireland to reflect growing biologics portfolio with ongoing investment in Cruiserath biologics facility.

Read more 
Merck presses the pause button on Keytruda trials

Merck presses the pause button on Keytruda trials

16 Jun 2017

The pause is to allow for additional information to be collected to better understand more reports of death in the Keytruda groups.

Read more 
FlyPharma Conference: Collaboration is the Key

FlyPharma Conference: "Collaboration is the Key"

16 Jun 2017

Delegates at the recent FlyPharma Conference pick out collaboration as their main goal for the coming year.

Read more 
Parexel and Sanofi collaborate to advance the use of wearable devices in life science industry

Parexel and Sanofi collaborate to advance the use of wearable devices in life science industry

15 Jun 2017

Preliminary findings from pilot study validate use of wearable technologies to collect data and manage clinical trials more effectively and efficiently.

Read more 
Lilly's Taltz shows promise for patients with active psoriatic arthritis

Lilly's Taltz shows promise for patients with active psoriatic arthritis

15 Jun 2017

Demonstrated significant improvements in disease signs and symptoms at 24 weeks among patients with active psoriatic arthritis who had prior inadequate response or intolerance to TNF inhibitors.

Read more 
LifeArc, previously MRC Technology, set to transform the medical research landscape

LifeArc, previously MRC Technology, set to transform the medical research landscape

15 Jun 2017

Investment will focus on new innovations in therapeutics for neurodegeneration, antibiotic resistance, cancer and respiratory diseases.

Read more